Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-67

I know today is rough. To be quite frank, I was considering selling on the open - it's tough to watch money drain from my account. But, I know the market is irrational and unfortunately this is the game we play.

Now, this isn't over. The results can't be better in OZ compared to the USA. There is a reason for this. I can sense the market knows that, especially those that understand what we have in hand. We just completed a Ph2 trial with SIGNIFICANT results, but an error in one data set....

CBD manufacturing differences is a huge *$%# upon management's behalf, or maybe it wasn't on them. I would be surprised if they didn't rectify this before the AGM.

Also, there is a lot of good in the company. We have 3 products in the pipeline, and our Ph2 pulled through with positives. I can not justify this MC given the development we have made since Phase 1b results across the board.

This isn't a gameover result. Look at $RAP for some confidence.....